(9:45 a.m.–10:05 a.m.)

Malaria Vaccines in the Field: A Perspective from the Africa Malaria Vaccine Testing Network

 

Wenceslaus Kilama, The African Malaria Vaccine Testing Network, Tanzania

(10:05 a.m.–10:30 a.m.)

Discussion

 

Moderator: Philip Russell

10:30 a.m.–11:00 a.m.

Break

11:00 a.m.–12:00 p.m.

SESSION II: MALARIA AS A PARADIGM

 

Stephen Hoffman, Naval Medical Research Institute, USA

(11:40 a.m.–12:00 p.m.)

Discussion

 

Moderator: Louis Miller, National Institutes of Health, USA

12:00 p.m.–1:00 p.m.

Lunch

1:00 p.m.–3:30 p.m.

SESSION III: CURRENT APPROACHES TO MALARIA VACCINE DEVELOPMENT

(1:00 p.m.–1:25 p.m.)

Preerythrocytic Vaccines

 

Ruth Nussenzweig, New York University Medical Center, USA

(5 min.)

Questions

(1:30 p.m.–1:55 p.m.)

Erythrocytic Vaccines

 

Graham Brown, The Walter and Eliza Hall Institute of Medical Research, Australia

(5 min.)

Questions

(2:00 p.m.–2:25 p.m.)

Transmission Blocking Vaccines

 

David Kaslow, National Institutes of Health, USA

(5 min.)

Questions

(2:30 p.m.–3:30 p.m.)

Discussion: Potential Immunologic Obstacles toDevelopment of an Optimal Multi-Immune Response, Multi-Stage Malaria Vaccine

 

Moderator: W. R. Ballou, Walter Reed Army Institute of Research, USA

3:30 p.m.–4:00 p.m.

Break



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement